Suchergebnisse - "Ma, Helen"

PubPharm (23)

1

Mature T-cell and NK-cell lymphoma involvement of the central nervous system : a single center experience

enthalten in: Leukemia & lymphoma | 2023

von Ma, H. | Marchi, E. | O'Connor, O. | +1

2

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells

enthalten in: Haematologica | 2023

von Jia, Y. | Han, L. | Ramage, C. | +17

3

How we approach the perioperative management of patients with chronic lymphocytic leukaemia receiving continuous cancer-directed therapies

enthalten in: British journal of haematology | 2023

von Ma, H. | Wang, S. | O'Brien, S. | +2

4

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia

enthalten in: Nature communications | 2022

von Baran, N. | Lodi, A. | Dhungana, Y. | +52

5

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2022

von Zhang, Q. | Riley-Gillis, B. | Han, L. | +38

ErratumIn: Signal Transduct Target Ther. 2022 Apr 1;7(1):110. - PMID 35365596

6

Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition

enthalten in: Blood advances | 2021

von Saito, K. | Zhang, Q. | Yang, H. | +20

7

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL : a multicenter phase 2 study

enthalten in: Blood | 2021

von Falchi, L. | Ma, H. | Klein, S. | +18

ErratumIn: Blood. 2022 Mar 10;139(10):1600. - PMID 35267001

8

Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma : updated results from an international multi-center phase I/II experience

enthalten in: Leukemia & lymphoma | 2020

von Sawas, A. | Ma, H. | Kuruvilla, J. | +10

9

A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder : efficacy of pralatrexate in primary refractory disease and review of the literature

enthalten in: Leukemia & lymphoma | 2019

von Ma, H. | Bhagat, G. | O'Connor, O.

10

New directions in treating peripheral T-cell lymphomas (PTCL) : leveraging epigenetic modifiers alone and in combination

enthalten in: Expert review of hematology | 2019

von Ma, H. | O'Connor, O. | Marchi, E.